Home LiteratureArticle Details
PMID: 21178482 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections.

Virulence ·Vol. 1 ·No. 5 ·2010-00-00 ·Pages 418-22

Rayamajhi M, Humann J, Kearney S, Hill KK, Lenz LL

Abstract

Type I and II interferons (IFNs αβ and γ) have opposing effects on immune resistance to certain pathogenic bacteria. While IFNγ generally plays a protective role, IFNαβ exacerbates Listeria monocytogenes and Mycobacterium tuberculosis infections. Our findings provided evidence that this increased susceptibility reflects a novel antagonistic cross talk between IFNαβ and IFNγ. Macrophages infected with L. monocytogenes strains that induce IFNαβ production responded poorly to IFNγ, as measured by reduced phosphorylation of STAT1 and reduced IFNγ-dependent gene expression. The impaired responsiveness to IFNγ correlated with reduced expression of its receptor, IFNGR, by both infected and bystander macrophages. Down regulation of IFNGR was dependent on responsiveness to IFNγ and mimicked by recombinant IFNβ. Mice lacking responsiveness to IFNαβ (IFNAR1 (-/-)) retained high IFNGR expression, developed higher expression of MHC-II on macrophages and DCs, and were more resistant to systemic L. monocytogenes infection--but only in the presence of IFNγ. Thus, the ability of IFNαβ to down regulate IFNGR provides an explanation for its ability to reduce responsiveness to IFNγ and to increase host susceptibility to bacterial infection. It remains to be determined whether and how such antagonistic interferon crosstalk benefits the host.

Keywords
Listeria monocytogenes Mycobacterium tuberculosis bacterial pathogens cytokine receptor gene expression immune suppression interferons macrophage activation
MeSH Terms
Animals Dendritic Cells/immunology Gene Expression Profiling Histocompatibility Antigens Class II/biosynthesis Interferon-alpha/immunology Interferon-beta/immunology Interferon-gamma/immunology Listeria monocytogenes/immunology Macrophages/immunology,microbiology Mice Phosphorylation Receptors, Interferon/biosynthesis STAT1 Transcription Factor/metabolism
Chemicals
Histocompatibility Antigens Class II Interferon-alpha Receptors, Interferon STAT1 Transcription Factor Stat1 protein, mouse interferon gamma receptor Interferon-beta Interferon-gamma
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Rayamajhi Manira
University of Colorado, Denver, CO, USA.
Humann Jessica
Kearney Staci
Hill Krista K
Lenz Laurel L
References (42)
42 references, click to expand
  1. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
    J Exp Med. 1988 Mar 1;167(3):1171-85 PMID: 2965208
  2. Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis.
    Immunity. 2009 Dec 18;31(6):974-85 PMID: 20064452
  3. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma.
    J Exp Med. 2010 Feb 15;207(2):327-37 PMID: 20123961
  4. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.
    N Engl J Med. 1996 Dec 26;335(26):1941-9 PMID: 8960473
  5. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response.
    Science. 2010 Jun 25;328(5986):1703-5 PMID: 20508090
  6. Interferon-gamma receptor-1 gene promoter polymorphisms (G-611A; T-56C) and susceptibility to tuberculosis.
    Scand J Immunol. 2006 Feb;63(2):142-50 PMID: 16476014
  7. Immune response in mice that lack the interferon-gamma receptor.
    Science. 1993 Mar 19;259(5102):1742-5 PMID: 8456301
  8. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis.
    J Immunol. 2007 Mar 1;178(5):3143-52 PMID: 17312162
  9. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
    Infect Immun. 2004 Nov;72(11):6603-14 PMID: 15501793
  10. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
    Science. 1993 Mar 19;259(5102):1739-42 PMID: 8456300
  11. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis.
    J Exp Med. 1997 Mar 3;185(5):921-31 PMID: 9120398
  12. Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens.
    J Exp Med. 1986 Apr 1;163(4):1030-5 PMID: 2419472
  13. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A.
    J Clin Invest. 2009 Jul;119(7):1931-9 PMID: 19603548
  14. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.
    N Engl J Med. 1996 Dec 26;335(26):1956-61 PMID: 8960475
  15. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.
    Nat Med. 2010 Apr;16(4):406-12 PMID: 20348925
  16. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes.
    J Exp Med. 2006 Apr 17;203(4):933-40 PMID: 16549598
  17. Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model.
    Infect Immun. 2008 Oct;76(10):4642-8 PMID: 18663004
  18. Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are regulated transcriptionally.
    J Immunol. 1988 Sep 1;141(5):1582-9 PMID: 2457621
  19. Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice.
    Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8233-8 PMID: 9653170
  20. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.
    J Exp Med. 2004 Aug 16;200(4):527-33 PMID: 15302899
  21. Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.
    J Immunol. 1985 Sep;135(3):1857-63 PMID: 3926890
  22. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response.
    Immunity. 2006 Jan;24(1):93-103 PMID: 16413926
  23. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
    J Immunol. 2004 May 15;172(10):6272-80 PMID: 15128816
  24. Context-specific functional effects of IFNGR1 promoter polymorphism.
    Hum Mol Genet. 2006 May 1;15(9):1475-81 PMID: 16600993
  25. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
    J Immunol. 2006 Apr 1;176(7):4323-30 PMID: 16547269
  26. Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are mediated by changes in steady-state levels of Ia mRNA.
    J Immunol. 1987 Jul 1;139(1):244-9 PMID: 3108400
  27. Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis.
    Am J Respir Crit Care Med. 2006 Aug 1;174(3):339-43 PMID: 16690980
  28. Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity.
    Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10191-6 PMID: 18632558
  29. Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections.
    J Immunol. 2010 Apr 1;184(7):3755-67 PMID: 20176744
  30. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
    J Immunol. 2005 Sep 1;175(5):3318-28 PMID: 16116224
  31. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.
    J Clin Invest. 2009 Jul;119(7):1910-20 PMID: 19487810
  32. Type I interferon production enhances susceptibility to Listeria monocytogenes infection.
    J Exp Med. 2004 Aug 16;200(4):437-45 PMID: 15302901
  33. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.
    J Clin Invest. 2010 May;120(5):1674-82 PMID: 20389020
  34. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages.
    J Immunol. 2008 Aug 1;181(3):2092-102 PMID: 18641348
  35. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
    J Exp Med. 1993 Dec 1;178(6):2249-54 PMID: 7504064
  36. TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms.
    PLoS One. 2009 Jul 24;4(7):e6329 PMID: 19629181
  37. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.
    J Exp Med. 2004 Aug 16;200(4):535-40 PMID: 15302900
  38. Disseminated tuberculosis in interferon gamma gene-disrupted mice.
    J Exp Med. 1993 Dec 1;178(6):2243-7 PMID: 8245795
  39. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP.
    J Exp Med. 2009 Aug 31;206(9):1899-911 PMID: 19652017
  40. MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection.
    J Immunol. 2009 Jul 15;183(2):1271-8 PMID: 19553532
  41. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.
    J Clin Invest. 1998 Jun 1;101(11):2364-9 PMID: 9616207
  42. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.
    Proc Natl Acad Sci U S A. 2001 May 8;98(10):5752-7 PMID: 11320211
Article Info
Journal
Virulence
Abbr.
Virulence
ISSN
2150-5608
Published
2010-00-00
Pages
418-22
Language
English
Region
United States
NLM ID
101531386
PMCID
PMC2957886
Subset
IM
Grants
NIAID NIH HHS · AI065357-NO2 · United States
NIAID NIH HHS · AI52066-06 · United States
NIAID NIH HHS · AI055701 · United States
NIAID NIH HHS · AI065638 · United States
NIAID NIH HHS · R01 AI065638 · United States
NIAID NIH HHS · T32 AI052066 · United States
NIAID NIH HHS · R01 AI055701 · United States
NIAID NIH HHS · U54 AI065357 · United States
NIAID NIH HHS · AI075-05 · United States
NIAID NIH HHS · R01 AI065638-05 · United States
NIAID NIH HHS · R21 AI055701 · United States
NIAID NIH HHS · R56 AI065638 · United States
NIAID NIH HHS · R01 AI055701-05 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com